Kidney and urologic disease status update: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(154 intermediate revisions by 7 users not shown)
Line 1: Line 1:
__NOTOC__
{{Organ System Project}}
System leader: '''[[User:Maneesha Nandimandalam|Maneesha Nandimandalam, MD]]'''
System leader: '''[[User:Maneesha Nandimandalam|Maneesha Nandimandalam, MD]]'''
==Status Updates==
{| class="wikitable" border="1" cellpadding="5" cellspacing="0" align="center" |class="wikitable"
|+
! colspan="2" style="background:#efefef;" |Resident survival guide Progress
|-
|Completed
|15
|-
|In progress
|6
|-
|Remaining
|3
|-
! colspan="2" style="background:#efefef;" |Primary care chapter Progress
|-
|Completed
|12
|-
|In progress
|6
|-
|Remaining
|5
|}


== List of Chapters Requiring Content ==
==Primary Care Topics==
{| class="wikitable sortable"
! colspan="4" |Primary care chapters
! colspan="3" |Primary care resident survival guides
|-
!Specialty
!Topic
!Author
!Status
!Resident Survival Guide Page
!Author
!Status
|-
|Nephrology||[[Acute kidney injury]]
|Farima kahe
|Complete
|[[Acute kidney failure resident survival guide]]||Kanwal Khmuani||Needs some review
|-
|Nephrology||[[Acidosis]]
|Carlos
|Needs review
|[[Acidosis resident survival guide]]|| ||P
|-
|Nephrology||[[Alkalosis]]
|Mydah
|In progress
|[[Alkalosis resident survival guide]]|| ||Needs content
|-
|Nephrology||[[Hyperkalemia]]
|Jogeeth Singh
|Complete
|[[Hyperkalemia resident survival guide]]||Mahmoud||Complete
|-
|Nephrology||[[Hypokalemia]]
|Cafer Zorkun
|Needs some content
|[[Hypokalemia resident survival guide]]|| ||Complete
|-
|Nephrology||[[Hypernatremia]]
|Feham Tariq
|Complete
|[[Hypernatremia resident survival guide]]||Mounika (Ahmed's scholar)||Being reviewed
|-
|Nephrology||[[Hyponatremia]]
|
|Needs content
|[[Hyponatremia resident survival guide]]||Priyamvada||Complete
|-
|Nephrology||[[Metabolic acidosis]]
|Sidra Kalsoom
|Needs review
|[[Metabolic acidosis resident survival guide]]||Ogheneochuko||Complete
|-
|Nephrology||[[Metabolic alkalosis]]
|Marufa Marium
|Needs review
|[[Metabolic alkalosis resident survival guide]]||Marufa Marium||Needs English Review
|-
|Nephrology||[[Respiratory acidosis]]
|Nasrin
|Assigned needs content
|[[Respiratory acidosis resident survival guide]]||Qasim Khurshid||Needs English Review
|-
|Nephrology||[[Respiratory alkalosis]]
|
|Complete
|[[Respiratory alkalosis resident survival guide]]||Rinky Agnes
|Needs review
|-
|Nephrology||[[Nephrolithiasis]]
|Amandeep Singh
|Complete
|[[Nephrolithiasis resident survival guide]]|| ||Complete
|-
|Nephrology
|[[Nocturia]]
|Sivakrishna Kumar, Nasrin
|Needs Review
|[[Nocturia resident survival guide]]
|Sidra
|In progress
|-
|Nephrology||[[Polyuria]]
|Amandeep Singh
|Complete
|[[Polyuria resident survival guide]]||Zaida
|In progress
|-
|Nephrology||[[Renal artery stenosis]]
|Shivam Singla
|Assigned
|[[Renal artery stenosis resident survival guide]]||Karol||Complete
|-
|Nephrology
|[[Hematuria]]
|Sivakrishna Kumar
|Needs review
|[[Hematuria resident survival guide]]
|Tayyaba Ali
|Needs English review
|-
|Nephrology
|[[Dysuria]]
|Nabeel
|In progress
|[[Dysuria resident survival guide]]
|Rinky
|Complete
|-
|Nephrology
|[[Flank pain]]
|Samantha Salomun
|In progress
|[[Flank pain resident survival guide]]
|Qasim Khurshid
|Needs English review
|-
|Nephrology
|[[Urinary tract infection]]
|Usama Talib
|Complete
|[[Urinary tract infection resident survival guide]]
|
|Complete
|-
|Nephrology
|[[Pyuria]]
|Sadaf
|Complete
|[[Pyuria resident survival guide]]
|Ibtisam Ashraf
|Needs English Review
|-
|Nephrology
|[[Hypertension]]
|Usama Talib
|Complete
|[[Hypertension resident survival guide]]
|
|Complete
|-
|Nephrology
|[[Edema generalized|Edema]]
|Mydah
|Complete
|[[Edema resident survival guide]]
|Sara zand
|In progress
|-
|Nephrology
|[[Urinary retention]]
|Luke Orazem
|Assigned(Sidra Kalsoom)
|[[Urinary retention resident survival guide]]
|Kanwal Khmuani
|Needs English review
|-
|Nephrology
|[[Urinary incontinence]]
|Maneesha
|In progress
|[[Urinary incontinence resident survival guide]]
|Maneesha
|Complete
|-
|}


{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
==Status Update==
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Category}}
{| class="wikitable" border="1" cellpadding="5" cellspacing="0" align="center" |class="wikitable"
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Chapters that need content}}
|+
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Assignment Status}}
! colspan="2" style="background:#efefef;" |Progress
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Scholar's name}}
|-
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Coach name}}
|Completed
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Completion Status}}
|35
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Review status}}
|-
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Reviewer name}}
|In progress
|4
|-
|Remaining
|37
|}
==List of Chapters Requiring Content==
 
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Category}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Chapters that need content}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Assignment Status}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Scholar's name}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Coach name}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Completion Status}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Review status}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Reviewer name}}
|-
| rowspan="41" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Kidney diseases
|-
|-
| rowspan="34" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Kidney diseases
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*  
*Abderhalden-Kaufmann-Lignac syndrome
*
| style="padding: 5px 5px; background: #F5F5F5;" |
*
| style="padding: 5px 5px; background: #F5F5F5;" |
*
| style="padding: 5px 5px; background: #F5F5F5;" |
*
| style="padding: 5px 5px; background: #F5F5F5;" |
*
| style="padding: 5px 5px; background: #F5F5F5;" |
*
| style="padding: 5px 5px; background: #F5F5F5;" |
*
|-
*
| style="padding: 5px 5px; background: #F5F5F5;" |
*
*Acute uric acid nephropathy
*  
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 34: Line 243:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Abderhalden-Kaufmann-Lignac syndrome
*Albuminuria
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 43: Line 252:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Analgesic nephropathy
*Balkan nephropathy
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Shakiba
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey, Ahmed
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-  
|-  
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Balkan nephropathy
*Bartter syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Tayyaba Ali
| style="padding: 5px 5px; background: #F5F5F5;" |Huda
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
*Beer potomania
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
*Boyd-Stearns syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[Branchio-oto-renal syndrome]]
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Shivam Singla
| style="padding: 5px 5px; background: #F5F5F5;" |Sara Mohsin
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
*Continuous veno-venous hemofiltration
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 62: Line 306:
|-  
|-  
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*  
*Calix diverticulum
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 71: Line 315:
|-  
|-  
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Continuous veno-venous hemofiltration
*Contrast-induced acute kidney injury
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 80: Line 324:
|-  
|-  
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Contrast-induced acute kidney injury
*Cholesterol emboli syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Abdul
| style="padding: 5px 5px; background: #F5F5F5;" |Ahmed Elsaiey
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Crush syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Akash Hans
| style="padding: 5px 5px; background: #F5F5F5;" |Ahmed
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 89: Line 342:
|-  
|-  
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Dent's disease
*C4 glomerulopathy
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |{{Norina Usman}}
| style="padding: 5px 5px; background: #F5F5F5;" |{{ADG}}
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
*Dent's disease
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 98: Line 360:
|-  
|-  
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Dialysis (LP)
*Dialysis (LP)
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 107: Line 369:
|-  
|-  
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Diuresis
*Diuresis
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 116: Line 378:
|-  
|-  
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Fibrillary immunotactoid glomerulopathy
*Fibrillary immunotactoid glomerulopathy
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 125: Line 387:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Haff disease
*Glomerulosclerosis
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 132: Line 394:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-  
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Hemodialysis (SP)
*Hypophosphatemia
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 143: Line 405:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* HIV associated nephropathy
*Haff disease
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Shakiba
| style="padding: 5px 5px; background: #F5F5F5;" |Swathi Joshi
| style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey,Ahmed
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Completed
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
*Hemodialysis (SP)
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Hypertensive nephropathy  
*Hypertensive nephropathy
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Nasrin
| style="padding: 5px 5px; background: #F5F5F5;" |Nasrin
Line 159: Line 430:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Kidney transplantation
*Kidney transplantation
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 169: Line 439:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Milk-alkali syndrome
*Multicystic dysplastic kidney
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 182: Line 451:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Multicystic dysplastic kidney
*Nephroptosis
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 192: Line 461:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Nephroptosis
*Nutcracker syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 202: Line 471:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Nutcracker syndrome
*[[Papillorenal syndrome]]
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Shivam Singla
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Sara Mohsin
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Papillorenal syndrome
*Peritoneal dialysis (SP)
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 220: Line 488:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Peritoneal dialysis (SP)
*Phosphate nephropathy
| style="padding: 5px 5px; background: #F5F5F5;" |Assingned
| style="padding: 5px 5px; background: #F5F5F5;" |Ayesha FJ
| style="padding: 5px 5px; background: #F5F5F5;" |Sogand
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Pyonephrosis
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Harshwardan Chawla
| style="padding: 5px 5px; background: #F5F5F5;" |Aditya
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Phosphate nephropathy
*Rhabdomyolysis
| style="padding: 5px 5px; background: #F5F5F5;" |Assingned
| style="padding: 5px 5px; background: #F5F5F5;" |Assingned
| style="padding: 5px 5px; background: #F5F5F5;" |Ayesha FJ
| style="padding: 5px 5px; background: #F5F5F5;" |Ayesha FJ,
| style="padding: 5px 5px; background: #F5F5F5;" |Sogand
| style="padding: 5px 5px; background: #F5F5F5;" |Sogand
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 241: Line 516:
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Rhabdomyolysis
*Rebound diuresis
| style="padding: 5px 5px; background: #F5F5F5;" |Assingned
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Ayesha FJ,
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Sogand
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
*Renal agenesis
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Shakiba
| style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey,Ahmed
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Renal artery stenosis
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 258: Line 542:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
*Renal papillary necrosis
 
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Nasrin
| style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey,Ahmed
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*Thin basement membrane disease
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |Marufa Marium
| style="padding: 5px 5px; background: #F5F5F5;" |Maneesha
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 291: Line 586:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Analgesic nephropathy
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Shakiba
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey,Ahmed
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Not done
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |HIV associated nephropathy
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Shakiba
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey,Ahmed
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Not done
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Milk-alkali syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Shakiba
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey,Ahmed
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Not done
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Bartter syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Tayyaba
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Huda
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Not done
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
Line 485: Line 780:
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Category}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Category}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Chapters that need content}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Chapters}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Assignment Status}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Assignment Status}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Scholar's name}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Scholar's name}}
Line 493: Line 788:
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Reviewer name}}
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Reviewer name}}
|-
|-
| rowspan="22" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Kidney diseases
| rowspan="35" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Kidney diseases
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Electrolyte imbalance (LP)
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Mehdi
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Hyponatremia
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Saeedeh
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Mahshid
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Hypernatremia
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Feham
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Hypokalemia
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Rc-Aida
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Mahshid
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Hyperkalemia
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Jogeet
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Amandeep
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Hypocalcemia
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Krishna
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Hasan
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Hypercalcemia
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Anmol
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Sudarshana Datta
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Glomerular Disease(LP)
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Farima
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Lupus Nephritis
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Aida/ Omer
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Iqra
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Rapidly progressive glomerulonephritis
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Nazia / Jogeet
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Aditya
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Membranous glomerulonephritis
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Sunny/ Seyd
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Amandeep
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Membranoproliferative glomerulonephritis
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |rc Arash
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Aditya
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |IgA nephropathy
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Dildar
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Goodpasture syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Akshun
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Farima
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Amyloidosis (LP)
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Shamila
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Primary amyloidosis
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 581: Line 930:
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Secondary amyloidosis
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 590: Line 939:
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Familial amyloidosis
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 599: Line 948:
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Wild-type(senile) amyloidosis
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 608: Line 957:
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Cardiac amyloidosis
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 617: Line 966:
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Beta-2 microglobulin related amyloidosis
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 626: Line 975:
|-
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Gelsolin related amyloidosis
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 632: Line 982:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |C3 glomerulopathy
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Vindhya
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Bladder cancer
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Farima Kahe
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Hydronephrosis
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Chandra
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Aditya
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Kidney stone
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Amandeep
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Aditya
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Polycystic kidney disease
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Khurram
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Anmol
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Nephritic syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Dildar
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Nephrotic syndrome
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Sadaf
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Post-streptococcal glomerulonephritis
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Manpreet
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Renal cell carcinoma
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Farima
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Anmol
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Renal osteodystrophy
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
Line 677: Line 1,062:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Renal tubular acidosis
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Aditya
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Sargun
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Renal vein thrombosis
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Saeedeh
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Mehdi
|-
| style="padding: 5px 5px; background: #F5F5F5;" |Wilms' tumor
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Sargun
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Farima
|-
|-
|}
|}

Latest revision as of 17:45, 25 May 2021

Organ System Project
Topics
Leaders & Members
Meetings' Summary

System leader: Maneesha Nandimandalam, MD

Status Updates

Resident survival guide Progress
Completed 15
In progress 6
Remaining 3
Primary care chapter Progress
Completed 12
In progress 6
Remaining 5

Primary Care Topics

Primary care chapters Primary care resident survival guides
Specialty Topic Author Status Resident Survival Guide Page Author Status
Nephrology Acute kidney injury Farima kahe Complete Acute kidney failure resident survival guide Kanwal Khmuani Needs some review
Nephrology Acidosis Carlos Needs review Acidosis resident survival guide P
Nephrology Alkalosis Mydah In progress Alkalosis resident survival guide Needs content
Nephrology Hyperkalemia Jogeeth Singh Complete Hyperkalemia resident survival guide Mahmoud Complete
Nephrology Hypokalemia Cafer Zorkun Needs some content Hypokalemia resident survival guide Complete
Nephrology Hypernatremia Feham Tariq Complete Hypernatremia resident survival guide Mounika (Ahmed's scholar) Being reviewed
Nephrology Hyponatremia Needs content Hyponatremia resident survival guide Priyamvada Complete
Nephrology Metabolic acidosis Sidra Kalsoom Needs review Metabolic acidosis resident survival guide Ogheneochuko Complete
Nephrology Metabolic alkalosis Marufa Marium Needs review Metabolic alkalosis resident survival guide Marufa Marium Needs English Review
Nephrology Respiratory acidosis Nasrin Assigned needs content Respiratory acidosis resident survival guide Qasim Khurshid Needs English Review
Nephrology Respiratory alkalosis Complete Respiratory alkalosis resident survival guide Rinky Agnes Needs review
Nephrology Nephrolithiasis Amandeep Singh Complete Nephrolithiasis resident survival guide Complete
Nephrology Nocturia Sivakrishna Kumar, Nasrin Needs Review Nocturia resident survival guide Sidra In progress
Nephrology Polyuria Amandeep Singh Complete Polyuria resident survival guide Zaida In progress
Nephrology Renal artery stenosis Shivam Singla Assigned Renal artery stenosis resident survival guide Karol Complete
Nephrology Hematuria Sivakrishna Kumar Needs review Hematuria resident survival guide Tayyaba Ali Needs English review
Nephrology Dysuria Nabeel In progress Dysuria resident survival guide Rinky Complete
Nephrology Flank pain Samantha Salomun In progress Flank pain resident survival guide Qasim Khurshid Needs English review
Nephrology Urinary tract infection Usama Talib Complete Urinary tract infection resident survival guide Complete
Nephrology Pyuria Sadaf Complete Pyuria resident survival guide Ibtisam Ashraf Needs English Review
Nephrology Hypertension Usama Talib Complete Hypertension resident survival guide Complete
Nephrology Edema Mydah Complete Edema resident survival guide Sara zand In progress
Nephrology Urinary retention Luke Orazem Assigned(Sidra Kalsoom) Urinary retention resident survival guide Kanwal Khmuani Needs English review
Nephrology Urinary incontinence Maneesha In progress Urinary incontinence resident survival guide Maneesha Complete

Status Update

Progress
Completed 35
In progress 4
Remaining 37

List of Chapters Requiring Content

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Kidney diseases
  • Abderhalden-Kaufmann-Lignac syndrome
  • Acute uric acid nephropathy
  • Albuminuria
  • Balkan nephropathy
  • Bartter syndrome
Assigned Tayyaba Ali Huda
  • Beer potomania
  • Boyd-Stearns syndrome
Assigned Shivam Singla Sara Mohsin
  • Continuous veno-venous hemofiltration
  • Calix diverticulum
  • Contrast-induced acute kidney injury
  • Cholesterol emboli syndrome
Assigned Abdul Ahmed Elsaiey
  • Crush syndrome
Assigned Akash Hans Ahmed
  • C4 glomerulopathy
Assigned Norina Usman, M.B.B.S[1] Aditya Ganti M.B.B.S. [2]
  • Dent's disease
  • Dialysis (LP)
  • Diuresis
  • Fibrillary immunotactoid glomerulopathy
  • Glomerulosclerosis
  • Hypophosphatemia
  • Haff disease
Assigned Swathi Joshi
  • Hemodialysis (SP)
  • Hypertensive nephropathy
Assigned Nasrin Elsaiey,Ahmed
  • Kidney transplantation
  • Multicystic dysplastic kidney
  • Nephroptosis
  • Nutcracker syndrome
Assigned Shivam Singla Sara Mohsin
  • Peritoneal dialysis (SP)
  • Phosphate nephropathy
Assingned Ayesha FJ Sogand
  • Pyonephrosis
Assigned Harshwardan Chawla Aditya
  • Rhabdomyolysis
Assingned Ayesha FJ, Sogand
  • Rebound diuresis
  • Renal agenesis
Assigned Shakiba Elsaiey,Ahmed
  • Renal artery stenosis
  • Renal papillary necrosis
Assigned Nasrin Elsaiey,Ahmed
  • Thin basement membrane disease
Assigned Marufa Marium Maneesha

In progress chapters

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Kidney diseases Cardiorenal syndrome Assigned Dina Huda
Analgesic nephropathy Assigned Shakiba Elsaiey,Ahmed Yes Not done
HIV associated nephropathy Assigned Shakiba Elsaiey,Ahmed Yes Not done
Milk-alkali syndrome Assigned Shakiba Elsaiey,Ahmed Yes Not done
Bartter syndrome Assigned Tayyaba Huda Yes Not done

Completed chapters

Category Chapters Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Kidney diseases Electrolyte imbalance (LP) Mehdi Yes Done Mehrian
Hyponatremia Saeedeh Yes Done Mahshid
Hypernatremia Feham Yes Done Elsaiey
Hypokalemia Rc-Aida Yes Done Mahshid
Hyperkalemia Jogeet Yes Done Amandeep
Hypocalcemia Krishna Yes Done Hasan
Hypercalcemia Anmol Yes Done Sudarshana Datta
Glomerular Disease(LP) Mehrian Yes Done Farima
Lupus Nephritis Aida/ Omer Yes Done Iqra
Rapidly progressive glomerulonephritis Nazia / Jogeet Yes Done Aditya
Membranous glomerulonephritis Sunny/ Seyd Yes Done Amandeep
Membranoproliferative glomerulonephritis rc Arash Yes Done Aditya
IgA nephropathy Dildar Yes Done Mehrian
Goodpasture syndrome Akshun Yes Done Farima
Amyloidosis (LP) Shamila Yes Done Mehrian
Primary amyloidosis
Secondary amyloidosis
Familial amyloidosis
Wild-type(senile) amyloidosis
Cardiac amyloidosis
Beta-2 microglobulin related amyloidosis
Gelsolin related amyloidosis
C3 glomerulopathy Vindhya Yes Done
Bladder cancer Farima Kahe Yes Done
Hydronephrosis Chandra Yes Done Aditya
Kidney stone Amandeep Yes Done Aditya
Polycystic kidney disease Khurram Yes Done Anmol
Nephritic syndrome Dildar Yes Done Mehrian
Nephrotic syndrome Mehrian Yes Done Sadaf
Post-streptococcal glomerulonephritis Manpreet Yes Done Mehrian
Renal cell carcinoma Farima Yes Done Anmol
Renal osteodystrophy
Renal tubular acidosis Aditya Yes Done Sargun
Renal vein thrombosis Saeedeh Yes Done Mehdi
Wilms' tumor Sargun Yes Done Farima